Non-invasive Validation of Non-invasive Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis

Completed

• Conditions: Diabetes Mellitus; Arterial Hypertension; Coronary Heart Disease; Healthy Control

• Registration Number: NCT03049709
• Lead Sponsor: Universitätsmedizin Mannheim

Brief Summary

There is growing evidence that central blood pressure is a better predictor of hypertensive end-organ damage and cardiovascular outcome than routine brachial readings.

The investigators aimed to evaluate the accuracy of a novel device for the non-invasive determination of central blood pressure based on automated oscillometric radial pulse wave analysis.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-05-01
• Study First Submitted: 2017-02-06
• Study First Submitted QC: 2017-02-07
• Study First Posted: 2017-02-10
• Primary Completion: 2017-05-31
• Study Completion: 2017-10-30
• Status Verified: 2017-12
• Last Update Submitted: 2017-12-24
• Last Update Posted: 2017-12-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 119

Inclusion Criteria

• cardiovascular disease, diabetes mellitus or healthy control

Exclusion Criteria

• inability to give informed consent
• hemodynamic instability

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
agreement of diastolic central blood pressure measurements	15 minutes
agreement of systolic central blood pressure measurements	15 minutes

Trial Locations

Locations (1)

Universitätsmedizin Mannheim; 🇩🇪 Mannheim, Germany